Abatacept Conversion in Kidney Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Abatacept
Related studies linked through entity extraction aliases.
An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Status
- UNKNOWN
- Phase
- PHASE3
Immune Modulators for Treating COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.
- Status
- UNKNOWN
- Phase
- N/A
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - TNFi vs Abatacept
- Status
- COMPLETED
- Phase
- N/A
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tofacitinib vs Abatacept
- Status
- COMPLETED
- Phase
- N/A
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept
- Status
- COMPLETED
- Phase
- N/A
Abatacept for Patients With COVID-19 and Respiratory Distress
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Abatacept for the Treatment of Giant Cell Arteritis
- Status
- RECRUITING
- Phase
- PHASE3
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
- Status
- TERMINATED
- Phase
- PHASE2
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Early Markers of Disease and Response to Therapy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4